As of 2025-06-20, the Fair Value of Hepion Pharmaceuticals Inc (HEPA) is -44.97 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.32 USD, the upside of Hepion Pharmaceuticals Inc is -14,239.98%.
With the market price of 0.32 USD and our fair value calculation, Hepion Pharmaceuticals Inc (HEPA) is not a good investment. Investing in HEPA stocks now will result in a potential loss of 14,239.98%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -20.35 | -32.72 | -42.20 | -48.93 | -13.19 | -31.48 |
| YoY growth | -189.06% | -60.79% | -28.97% | -15.94% | 73.04% | -44.34% |
| Market Cap (mil) | 0.47 |
| P/E | |
| Forward P/E |
| EPS | -8.99 |
| Avg earnings growth rate | -44.34% |
| TTM earnings | -13.19 |